Compound Monoammonium Glycyrrhizinate S Sodium Chloride Injection
Function and Efficacy
Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell
Ingredients
This product is a compound preparation, whose components are: monoammonium glycyrrhizinate S (C42H65NO16·2H20), glycine (C2H5NO2), cysteine hydrochloride (C3H7NO2S·HCl·H2O), and sodium chloride (NaCl).
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| GlycineIngredients |
Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell More |
56-40-6 | 27 | |
| L-Cysteine monohydrochlorideIngredients |
Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell More |
52-89-1 | 11 | |
| Sodium chlorideIngredients |
Monoammonium glycyrrhizinate has a strong affinity for liver cholesterol metabolism enzymes, thereby hindering the inactivation of cortisol and aldosterone. After use, it shows obvious corticosteroid-like effects, such as anti-inflammatory, anti-allergic and protective membrane structure, etc.; there are no obvious corticosteroid-like side effects. This product can promote bile pigment metabolism, reduce the release of ALT and AST; induce γ-IFN and interleukin II, increase NK cell activity and OKT4/OKT8 ratio and activate the reticuloendothelial system; inhibit mast cell release of histamine; inhibit the formation of cell membrane phospholipase A2 (PL-A2) and prostaglandin E2 (PGE2) and granulomatous reaction; inhibit the production and formation of free radicals and lipid peroxides, reduce the activity of proline hydroxylase; regulate calcium ion channels, protect lysosomal membranes and mitochondria, and reduce cell More |
7647-14-5 | 43 |
Appearance
This product is a colorless clear liquid.
Indication
It is used for abnormal liver function caused by acute, chronic and persistent hepatitis; it has a certain auxiliary therapeutic effect on toxic hepatitis, traumatic hepatitis and cancer. It can also be used for food poisoning, drug poisoning, drug allergy, etc.
Usage and Dosage
Slow intravenous drip. 40mg~160mg (calculated as monoammonium glycyrrhizinate) once a day, slow drip.
Adverse Reactions
Poor appetite, nausea, vomiting, abdominal distension, as well as itchy skin, urticaria, dry mouth and edema; common cardiovascular and cerebrovascular system symptoms include headache, dizziness, palpitations and increased blood pressure. The above symptoms are generally mild and do not affect treatment.
Precautions
1. Patients who are allergic to this product are prohibited from using this product. 2. Patients with severe hypokalemia and hypernatremia are prohibited from using this product. 3. Patients with hypertension and heart failure are prohibited from using this product. 4. Patients with renal failure are prohibited from using this product.
Drug Interactions
Not yet clear.
Storage
Keep tightly closed in a cool, dark place.
Packaging Specification
100ml: monoammonium glycyrrhizinate S80mg, cysteine hydrochloride 60mg, glycine 0.8g
Manufacturer
Qingdao Jinfeng Pharmaceutical Co., Ltd.
-
Founded in:
1995-12-30 -
Address:
No. 3 Yantai Road, Laixi City, Qingdao -
Tax NO.:
91370285614301430T -
Registered Funds:
$686,200 -
Email: